SCHEMBL13769052

SCHEMBL13769052

Nc1ccc(N2CCN(C3CC3)CC2)cn1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.50
MTOR P42345 4/20 0.50
L3MBTL3 Q96JM7 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
HSD11B1 P28845 1/20 0.42
TRPV6 Q9H1D0 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42
GRIN2B Q13224 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20740433 0.94 L3MBTL3 (0.46) PIK3CAMTORL3MBTL3L3MBTL1CHRNB2
SCHEMBL20740477 0.94 HRH3 (0.48) PIK3CAMTORL3MBTL3L3MBTL1DRD2
SCHEMBL20740505 0.92 L3MBTL3 (0.45) PIK3CAMTORL3MBTL3L3MBTL1HSD11B1
SCHEMBL20740625 0.92 L3MBTL3 (0.45) PIK3CAMTORL3MBTL3L3MBTL1HSD11B1
SCHEMBL13769029 0.87 L3MBTL3 (0.64) L3MBTL3L3MBTL1HRH3
SCHEMBL10126764 0.86 ACVR1 (0.53) PIK3CAMTORL3MBTL3L3MBTL1
SCHEMBL2724459 0.86 L3MBTL3 (0.62) L3MBTL3L3MBTL1HRH3
SCHEMBL14916901 0.86 PIK3CA (0.50) PIK3CAMTORCHRNB2CHRNA4HSD11B1
SCHEMBL2300495 0.84 MAP4K4 (0.49) PIK3CAMTORL3MBTL3L3MBTL1CHRNB2
SCHEMBL2724584 0.83 L3MBTL1 (0.46) PIK3CAMTORL3MBTL3L3MBTL1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116924976-A Diaryl heterocyclic amine compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2023-10-24 CN disclosed
WO-2020224568-A1 CDK INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2020-11-12 WO disclosed
WO-2009085185-A1 FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS AMGEN INC. (US) 2009-07-09 WO disclosed